FDA 483 - Phoenix Diagnostics, Inc. - March 17, 2022

Phoenix Diagnostics, Inc. in Natick, MA, received a Form FDA 483 with four observations following an inspection. The firm demonstrated inadequate procedures for corrective and preventive actions, employee training, control of nonconforming materials, and quality audits. One observation regarding training was a repeat finding, indicating persistent issues with their quality system.